A treatment approach for atopic dermatitis

Pediatric Annals

Volumn 34, Issue 3, 2005, Pages 201-210

  Dohil, Magdalene A ^a,b   Eichenfield, Lawrence F ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMCINONIDE; ANTIHISTAMINIC AGENT; ANTIMETABOLITE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCINEURIN; CALCINEURIN INHIBITOR; CETIRIZINE; CLOBETASOL PROPIONATE; CORMAX; CORTICOSTEROID; CYCLOSPORIN A; DESOXIMETASONE; DIFLORASONE DIACETATE; DOXEPIN; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE VALERATE; IMMUNOGLOBULIN; MAXIVATE; MOMETASONE FUROATE; PSEUDOMONIC ACID; PSORCON E; RECOMBINANT GAMMA INTERFERON; TACROLIMUS; TOPICORT LP; TRANSCRIPTION FACTOR NFAT; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALGORITHM; ANTIBIOTIC PROPHYLAXIS; ATOPIC DERMATITIS; CANCER RISK; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG POTENCY; HERPES ZOSTER; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRURITUS; RASH; REVIEW; SIDE EFFECT; SKIN BURNING SENSATION; SYSTEMATIC REVIEW;

EID: 15444367192     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20050301-09     Document Type: Review

References (38)

1. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000;43:649-655.
2. Ring J, Kramer U, Schafer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol. 2001;13:701-708.
3. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(suppl):44-7.
4. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49(6):1088-1095.
5. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351(9111):1225-1232.
6. Schafer T, Heinrich J, Wjst M, et al. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol. 1999;104(6):1280-1284.
7. Beck LA, Leung DY. Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol. 2000; 106(5 suppl):S258-S263.
8. Sator PG, Schmidt JB, Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol. 2003;48(3):352-358.
9. Nassif A, Chan SC, Storrs FJ, Hanifin JM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol. 1994;130(11):1402-1407.
10. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol. 1999;104(3 pt 2):S114-S122.
11. Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001; 107(5):891-896.
12. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol. 1995;95(6):1179-1190.
13. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358(9288):1129-1133.
14. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis; 18 months' treatment and 18 months' post treatment follow-up. J Allergy Clin Immunol. 2001;108(6):929-937.
15. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001;357(9262):1076-1079.
16. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47(2):198-208.
17. Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 2000; 106(1 pt 1):5-16.
18. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ. 2002;324(7340):768.
19. Friedlander SF, Hebert AA, Allen DB. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. J Am Acad Dermatol. 2002;46(3):387-93.
20. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138(2):293-296.
21. Berth-Jones J, Graham-Brown RA, Marks R, et al. Long-term efficacy and safety of cyclosporin in adult atopic dermatitis. Br J Dermatol. 1997;136(1):76-81.
22. Protopic (package insert). Deerfield, IL: Fujisawa Healthcare Inc.
23. Palier A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44(1 suppl):S47-S57.
24. Meingassner JG, Grassberger M, Fahrngruber H, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol. 1997;137(4):568-576.
25. Elidel (package insert). East Hanover (NJ): Novartis Pharmaceuticals Corporation.
26. Ellis C, Luger T, Abeck D, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003; 148(suppl 63):3-10.
27. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol. 2003;112(6 Suppl):140-150.
28. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25(7):559-566.
29. Grundmann-Kollmann M, Behrens S, Podda M, et al. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol. 1999;40(6 pt 1):995-997.
30. Eichenfield LF, Hanifin JM, Beck LA, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics. 2003; 111(3):608-616.
31. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112(6 suppl):S118-S127.
32. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy. 2004;59 Suppl 78:86-92.
33. Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. 1997. Publication No. 97-4051. Available at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed February 14, 2005.
34. Williams H. "Objective" measures of atopic dermatitis severity: in search of the holy grail. Arch Dermatol. 2003;139(11):1490-1492.
35. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol. 2000 Jun;136(6):763-769.
36. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003;120(6):932-941.
37. Sugarrnan JL, Fluhr JW, Fowler AJ, et al. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol. 2003;139(11):1417-1422.
38. Gutgesell C, Frolich JC, Neumann C. Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores. Br J Dermatol. 2002;147(5):914-919.